(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 105.81% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.05%, and it is also forecast to beat the US market's average forecast revenue growth rate of 57.33%.
Neuronetics's revenue in 2025 is $72,711,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2025 to be $4,541,503,974, with the lowest STIM revenue forecast at $4,485,361,091, and the highest STIM revenue forecast at $4,597,646,856.
In 2026, STIM is forecast to generate $4,914,626,535 in revenue, with the lowest revenue forecast at $4,912,957,423 and the highest revenue forecast at $4,916,295,648.